Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2022 Publisher: Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics, PO Box 62027, Sylvia Park Auckland 1644, Freecall: 0800 283 684, Email: medinfo.australia@sanofi.com
PLAQUENIL 200mg Tablet, film coated.
| Pharmaceutical Form |
|---|
|
Film coated tablet. White to off-white peanut shaped tablets, marked “Plaquenil” in black ink on one face of the tablet. |
Hydroxychloroquine sulfate 200mg equivalent to 155mg hydroxychloroquine.
For full list of excipients, see section 6.1 List of excipients.
| Active Ingredient | Description | |
|---|---|---|
| Hydroxychloroquine |
Hydroxychloroquine is a antimalarial agent with have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but its role is not known. |
| List of Excipients |
|---|
|
Tablet core: Calcium hydrogen phosphate dihydrate Film coating: Hypromellose |
Plaquenil is supplied as 100 tablets in a plastic HDPE bottle with a child resistant closure.
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics, PO Box 62027, Sylvia Park Auckland 1644, Freecall: 0800 283 684, Email: medinfo.australia@sanofi.com
31 December 1969
| Drug | Countries | |
|---|---|---|
| PLAQUENIL | Australia, Canada, Cyprus, Germany, Estonia, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, Tunisia, Turkey, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
